Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus.
about
Hepatitis B and A vaccination in HIV-infected adults: A reviewImmunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.Systemic immune activation in HIV infection is associated with decreased MDC responsiveness to TLR ligand and inability to activate naive CD4 T-cells.Viral hepatitis in HIV infection.Phage display creates innovative applications to combat hepatitis B virusOut-of-sequence signal 3 as a mechanism for virus-induced immune suppression of CD8 T cell responses.2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.Long-term durability of immune responses after hepatitis A vaccination among HIV-infected adults.Seroprevalence of hepatitis B virus among adults at high risk for HIV transmission two decades after implementation of nationwide hepatitis B virus vaccination program in Taiwan.Hepatitis A Virus among Drug Users and the Role of Vaccination: A ReviewFactors influencing the severity of acute viral hepatitis A.Comparison of the Immunogenicity of Various Booster Doses of Inactivated Polio Vaccine Delivered Intradermally Versus Intramuscularly to HIV-Infected Adults.Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individuals.Association of CMV, HBV, or HCV co-infection with vaccine response in adults with well-controlled HIV infectionNon-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunitiesVaccination and immunization against travel-related diseases in immunocompromised hosts.Human papillomavirus vaccine: widening the scope for cancer prevention.Vaccination against viral hepatitis of HIV-1 infected patients.Challenges for HCV vaccine development in HIV-HCV coinfection.Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine.Supercritical fluid extraction provides an enhancement to the immune response for orally-delivered hepatitis B surface antigen.Hepatitis B virus vaccination in HIV-infected people: A review.Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination.Serological response to one intradermal or intramuscular hepatitis B virus vaccine booster dose in human immunodeficiency virus-infected nonresponders to standard vaccinationBioencapsulation of the hepatitis B surface antigen and its use as an effective oral immunogen.Retrobulbar optic neuritis after Hepatitis A vaccination in a HIV-infected patient.Changes in hepatitis A virus seroepidemiology in HIV-infected Brazilian patients.Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.Does chronic hepatitis B infection affect the clinical course of acute hepatitis A?Humoral and cell-mediated immune responses after a booster dose of HBV vaccine in HIV-infected children, adolescents and young adults.Efficacy of Hepatitis B Vaccination among Children in Special Region of Yogyakarta, Indonesia: Evaluation of Humoral and Cellular Immunity.Hepatitis a and e infection in international travellers.
P2860
Q26799782-7C176EC0-F19F-4019-AFED-9B34A68AF4E5Q33623763-35B50801-2E23-43D6-A152-93590539FCA9Q34017771-756A5CD8-698A-4CD9-8231-ABAE45ACB28FQ34086980-D17FEF8C-7193-4436-94DB-464BF92D4807Q34137308-9F74B413-BF4F-46FE-955A-A8298DE17148Q34257444-9F1FEE79-3927-4AC7-9985-F25A0426E9E4Q34390072-999A2676-9B13-43C4-B510-F2A77D621AAAQ35000898-03E7113E-A99A-4BA0-8B6A-079BE535030CQ35108823-F424BEC8-77F8-413B-9E92-B2486D6B328DQ35747360-395A4BDF-9E10-4685-9B16-3C7F8BC9E0A2Q35832983-DCDCE707-BE5F-4CC4-BA7E-91BD85257975Q35965234-B106D015-928D-4707-9A3B-549B1D1F6DFBQ36544183-4F4E66AE-880C-4A57-92B7-32F606BF13E4Q37131078-B61702BC-40B7-4B84-A89A-A770A2F94729Q37180845-8B3AD730-A2F5-41F1-A70E-067B90FF053AQ37194799-4DF7FC56-C5AF-4D11-9F46-AF3E69C5349BQ37861634-CD57AC2F-F8D1-4E1C-B3BD-B9FC0420E257Q38013507-3CE61674-A540-4ABF-950C-87307CFB62B2Q38036684-93D20D3B-4561-42DF-9250-559A1F93090FQ38306933-0073660B-3AB9-42D3-97CB-B49F93E4B35CQ38966684-7CE32FAC-F9F0-4D09-B59F-C6536EAAC459Q39166033-915DD0BE-A215-4802-A80D-AA7E4CED7093Q40992209-D2427689-0AE2-4451-9969-36292C714920Q41366504-82826269-93E3-4F27-BD17-0A73BBE02BFFQ41869849-B3E5C9CE-B7FA-416D-AE97-59DE1207F074Q43281020-10987F1D-8514-49BA-9778-E967C95ADF47Q44901216-1B7D5D73-5598-40C8-9420-280AE21FE157Q45097162-D26185D3-080B-451C-8EB9-BF25CD9C69B7Q46674441-7C318A71-F561-48F4-A6BC-8BF43D488CC4Q50000083-9A93413E-720F-46ED-BF60-CB1E37BBD712Q50055700-84BAF883-956E-48C0-8395-24C6C4F121E0Q53156790-8C2005C7-3EE4-40C9-A903-918A66A6EDC1
P2860
Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Hepatitis A and B immunization ...... human immunodeficiency virus.
@ast
Hepatitis A and B immunization ...... human immunodeficiency virus.
@en
type
label
Hepatitis A and B immunization ...... human immunodeficiency virus.
@ast
Hepatitis A and B immunization ...... human immunodeficiency virus.
@en
prefLabel
Hepatitis A and B immunization ...... human immunodeficiency virus.
@ast
Hepatitis A and B immunization ...... human immunodeficiency virus.
@en
P1476
Hepatitis A and B immunization ...... human immunodeficiency virus.
@en
P2093
Jeffrey C Laurence
P304
P356
10.1016/J.AMJMED.2005.07.024
P407
P478
118 Suppl 10A
P577
2005-10-01T00:00:00Z